Life Science Leader Magazine Supplements

CRO Leadership Awards 2017

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/818304

Contents of this Issue

Navigation

Page 36 of 45

CAPABILITIES COMPATIBILITY EXPERTISE RELIABILITY QUALITY K E Y W W W.C R O L E A D E R S H I PA W A R D S .C O M Company Profiles 2017 CRO LEADERSHIP AWARDS WINNERS LIFESCIENCELEADER.COM THE CRO LEADERSHIP AWARDS 2017 35 SERVICES & CAPABILITIES: Eurofins provides pharma discovery, preclinical, early development, central laboratory, cGMP product testing, bioana- lytical, genomic, medical device and human safety testing services. THERAPEUTIC AREAS: Eurofins Biopharma Services supports all therapeutic areas within the Bio/Pharma and Medical Device industries. DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Pre-Clinical, Clinical, Phase 1, Phase 2, Phase 3 Formulated Drug Production: Dosage Form Production, Packaging, Logistics MAIN SERVICE AREAS: Lab, Pre-Clinical, Full Service Clinical "To receive the CRO Leadership Award for the quality category is a great achievement. Eurofins' dedication to quality is embedded in our values, our mission, and the work we perform around the world every day. We are pleased that the bio/phar- maceutical industry continues to recognize Eurofins as a leader in delivering quality testing results." GILLES MARTIN CEO CATEGORIES WON: Eurofins Scientific Kraainem, Belgium www.eurofins.com Phone: 717-656-2300 Contact: Dirk Bontridder Email: pharma@eurofins.com Key locations: Lancaster, PA; San Diego, CA; St. Charles, MO; Toronto, Canada; Munich, Germany; Milan, Italy; Sydney, Australia; Tokyo, Japan INDIVIDUAL ATTRIBUTE AWARDS: offered innovative solutions SERVICES & CAPABILITIES: Full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. THERAPEUTIC AREAS: cardiovascular, CNS anal- gesia, CNS neurology, CNS psychiatry, endocrinol- ogy, gastroenterology/hepatology, hematology, immunology & inflammation, infectious disease, oncology, ophthalmology, respiratory, women's health, cross-functional solutions, biosimilars, medical devices, orphan & rare diseases, pedi- atrics DRUG LIFE CYCLE STAGES: Research & Development: Phase 1, Phase 2, Phase 3 MAIN SERVICE AREAS: Full Service Clinical "INC Research continues to perform well in awards based on relationships and quality because of the undying commitment of our global workforce to deliver exceptional results for our customers. The CRO Leadership Awards are further validation that our customers recognize the value we bring to every relationship as INC's Trusted Process and commitment to providing accredited, passionate and skilled professionals ensure that we provide the very best processes, procedures and expertise to all projects." ALISTAIR MACDONALD CEO CATEGORIES WON: INC Research Raleigh, North Carolina www.incresearch.com Phone: 919-876-9300 Contact: Michael Kleppinger Email: michael.kleppinger@incresearch.com Key locations: Raleigh, NC; Camberley, UK; Singapore; Austin, TX; Toronto, Canada; Beijing, China; Mexico City, Mexico; Tokyo, Japan INDIVIDUAL ATTRIBUTE AWARDS: responsiveness SERVICES & CAPABILITIES: full service, biostatistics, monitoring, data mgmt., drug safety & pharmacovigi- lance, feasibility & study start-up, staffing, late-stage, market research, medical & scientific affairs, medical writing, patient recruitment, risk mgmt., statistical programming THERAPEUTIC AREAS: Therapeutically aligned project teams. Expertise across all areas including biosimilars, cardiovascular, dermatology, endocrine & metabolic, gastroenterology, hematology, infectious disease, immunology & inflammation, neurosci- ence, oncology, pediatrics, rare disease, respiratory, women's health. DRUG LIFE CYCLE STAGES: Research & Development: Pre-Clinical, Clinical, Phase 1, Phase 2, Phase 3 MAIN SERVICE AREAS: Lab, Full Service Clinical "inVentiv Health is honored be recognized with a Life Science Leadership Award. This recognition is an indication that our comprehensive outsourc- ing model – combining a leading full-service CRO with the industry's only Contract Commercial Organization (CCO) – provides value-enhancing services to clients navigating a complex environ- ment. It also celebrates our employees who apply deep therapeutic and operational expertise to create better, faster, and smarter ways to help biopharmaceutical clients accelerate the delivery of therapies to market." MICHAEL J. MCKELVEY, PH.D EVP, inVentiv Health & President, inVentiv Health Clinical CATEGORIES WON: inVentiv Health Boston, Massachusetts www.inventivhealth.com Phone: 800-416-0555 Contact: Gregory Skalicky Email: clinical.information@inventivhealth.com Key locations: Boston, MA; Princeton, NJ; Blue Bell, PA; New York, NY; Maidenhead, England; Seoul, Korea; Shanghai, China; Tokyo, Japan INDIVIDUAL ATTRIBUTE AWARDS: responsiveness

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Leadership Awards 2017